Screening: why, when, and how. (Q37523194)

20 August 2017

title

Screening: why, when, and how. (English)

1 reference

20 August 2017

Carmine Zoccali

0 references

Friedo W Dekker

0 references

Kitty J Jager

1 reference

20 August 2017

Diana C Grootendorst

1 reference

20 August 2017

language of work or name

English

0 references

publication date

17 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

page(s)

694-699

1 reference

Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

The global burden of chronic kidney disease: how valid are the estimates?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Testing for chronic kidney disease: a position statement from the National Kidney Foundation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Screening for CKD with eGFR: doubts and dangers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Effect of lipid reduction on the progression of renal disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Long-term effects of antihypertensive agents on proteinuria and renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Glomerular filtration rate: screening cannot be recommended on the basis of current knowledge

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Clinical utility of trace proteinuria for microalbuminuria screening in the general population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Screening for early chronic kidney disease--what method fits best?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Formula-based estimates of the GFR: equations variable and uncertain

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Assessing kidney function--measured and estimated glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Cross-Classification of Microalbuminuria and Reduced Glomerular Filtration Rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Unreferred chronic kidney disease: a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of r

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Screening for proteinuria in US adults: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

A simple algorithm to predict incident kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Bias in clinical research

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

An evidence-based approach to earlier initiation of dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

When to initiate dialysis: effect of proposed US guidelines on survival.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.232

7 January 2021

Identifiers

DOI

10.1038/KI.2009.232

1 reference

20 August 2017

1 reference